Home' Australian Pharmacist : Australian Pharmacist August 2014 Contents Australian Pharmacist August 2014 I ©Pharmaceutical Society of Australia Ltd.
Kardachi gets fourth term
Grant Kardachi was re-elected for a
fourth term as National President of the
Pharmaceutical Society of Australia at
the July Board meeting in Canberra.
The National Board also elected Michelle
Lynch as Vice President and re-elected
Joe Demarte as the other Vice President.
Ms Lynch replaces Dr Claire O'Reilly who
retired from the National Board at the
end of her term earlier this year.
Mr Kardachi said he was honoured to
be have been chosen once again by the
Board to lead PSA over the coming year.
He said he was delighted to have two
Vice Presidents of the calibre of Ms Lynch
and Mr Demarte to work with.
'Over the past few years PSA has
gained greater respect, recognition
and acceptance as being the major
representative voice of the whole of the
pharmacy profession in this country,'
Mr Kardachi said.
'We are entering an important period
for the profession with negotiations
for the next Community Pharmacy
Agreement set to begin soon and new
business models for the way we practise
becoming increasingly important to our
'The next year will no doubt again be one
that challenges us as a profession but it
is how we rise to those challenges that
defines us one of the most respected of
all professions in this country.'
Mr Kardachi said PSA had developed
close working relationships with a wide
range of stakeholders with a view to
seeking opportunities for pharmacists
while also improving the health
outcomes of the communities that
'These two Vice Presidents bring great
skills and expertise to the Board at a
critical time for pharmacists. The depth
of the new PSA Board Executive will give
us added strength in our advocacy for
our members and will ensure that PSA
continues to be the voice of pharmacy,'
'I would also like to thank the outgoing
Vice President, Dr Claire O'Reilly, for her
commitment and dedication to PSA and
all its members during her terms in office'.
Global e ort on resistant
The British Prime Minister, David
Cameron, has pledged that the UK will
lead a global effort to develop new drugs
to tackling antibiotic resistant bugs.
Last month he announced an inquiry
into why drugs have not emerged to
combat antibiotic resistance and called
for a coordinated global response to the
emergence of untreatable bacteria.
He said that antibiotic-resistant
superbugs threaten to plunge the world
back to the 'dark ages' of medicine and
were one of the biggest health threats
facing the world today.
'This is not some distant threat, but
something happening right now,' Mr
Cameron told the Times. 'If we fail to act,
we are looking at an almost unthinkable
scenario where antibiotics no longer
work, where treatable infections and
injuries will kill once again. That simply
cannot be allowed to happen and I want
to see a stronger, more coherent global
response,' he said.
Closer to home, the ABC last month
reported that researchers from the
School of Biology from the Australian
National University have found
bugs that are resistant to a banned
antibiotic found in chickens for sale
in major supermarkets and butchers.
The scientists took samples from
supermarkets and a butcher around
Canberra. In those chicken samples
contaminated with E.coli bacteria, almost
two thirds of the bugs were resistant to
some form of antibiotic which means
that if a human were to get sick from the
contaminated chicken meat, doctors
would find the illness difficult to treat.
Researchers Belinda Vangchhia and
Professor David Gordon told the ABC
that their findings suggest that the food
people consume is a significant source of
Also last month NPS MedicineWise warned
that a lack of understanding about when
to use antibiotics, and a desire to get back
to work faster after a cold or flu, could be
contributing to the spread of antibiotic
resistance in Australia.
A Galaxy Research poll commissioned by
NPS MedicineWise indicated that 65% of
workers mistakenly believe that taking
antibiotics will help them get over their
cold or flu and back to work sooner.
Dr Andrew Boyden, NPS MedicineWise
clinical advisor, said: 'Antibiotics only
work for bacterial infections, not viral
infections like colds and flu -- but these
new findings show many people still
mistakenly believe that antibiotics make a
difference when they have a virus.
'To help prevent the growing problem of
antibiotic resistance it's important that
all Australians recognise and address this
misconception. Using antibiotics when
they're not needed, like for colds and flu,
is contributing to antibiotic resistance.
This is making bacterial infections, such
as pneumonia and tuberculosis, harder to
treat with potentially dire consequences,'
The polling, showed that:
• 71% of Gen-Y workers (aged 18--34) think
antibiotics will speed their return to work
when they have a cold or flu compared
with 60% of baby boomer workers (aged
50--64) who were surveyed
• Most Australian workers (94%) have gone
into work when they had a cold or flu
(See page 30 for more on the global threat
of antibiotic resistance.)
Links Archive Australian Pharmacist September 2014 Australian Pharmacist July 2014 Navigation Previous Page Next Page